Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Transplantation and Cellular Therapy|March 29, 2021
Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell TransplantationEmily C Liang, Lori S Muffly, Parveen Shiraz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel AgentsChristopher Lemieux, Laura J Johnston, Robert Lowsky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendationsSergio Giralt, Luciano Costa, Jeffrey Schriber, et al.
Bone Marrow Transplantation|August 13, 2020
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myelomaChristopher Lemieux, Lori S Muffly, Andrew Rezvani, et al.
Transplantation and Cellular Therapy|May 18, 2022
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern EraEmily C Liang, Juliana Craig, Stefan Torelli, et al.
Blood Advances|September 14, 2021
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John Baird, et al.
Oncotarget|November 28, 2018
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitutionJoshua N Kellner, Eveline M Delemarre, Eric Yvon, et al.
Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.
Blood Advances|August 25, 2021
Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipientsKent P Jensen, David A Hongo, XuHuai Ji, et al.
Cancer Research|June 3, 2017
A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell TransplantJohn A Ronald, Byung-Su Kim, Gayatri Gowrishankar, et al.
Pageof 3